Back to Search
Start Over
Bortezomib for neuromyelitis optica spectrum disorder: a new therapeutic option for the more severe forms? Does bortezomib inform our understanding of the immunology underlying neuromyelitis optica spectrum disorders?
- Publication Year :
- 2017
- Publisher :
- American Medical Association), 2017.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.dedup.wf.001..1206feea1edf2b0192a420634fe162f1
- Full Text :
- https://doi.org/10.1001/jamaneurol.2017.3447